health · HHS-CDC-NCHHSTP
Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP)
Centers for Disease Control - NCHHSTP · CDC-RFA-PS-27-0009
Total Program Funding
$450.0M
Expected Awards
60
Deadline
TBD
GRANTQUICK SUMMARYPlain-English Overview
Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP). Centers for Disease Control - NCHHSTP. This NOFO supports integrated viral hepatitis surveillance and prevention programs in states, territories, and large cities in the United States. Key strategies include viral hepatitis outbreak response and surveillance for hepatitis A, acute and chronic hepatitis B, and... $450,000,000 total program funding; ~60 awards expected.
Who Should Apply
Other eligible entities, State governments, Special district governments, City/township governments, County governments
Who Should NOT Apply
Organizations not matching the eligible applicant types listed above
Key Requirements (Plain English)
- •Eligible applicants include: The 51 state health departments or their bona fide agents, including the District of Columbia
💡 GrantQuick Tip
High-value award — invest significantly in proposal quality. Consider hiring a grant writer.
Competitiveness: Moderate to high — federal grants are always competitive
What This Grant Funds
This NOFO supports integrated viral hepatitis surveillance and prevention programs in states, territories, and large cities in the United States. Key strategies include viral hepatitis outbreak response and surveillance for hepatitis A, acute and chronic hepatitis B, and acute, chronic, and perinatal hepatitis C. Surveillance activities include developing and utilizing disease registries, conducting data matching, generating data summaries, utilizing data to monitor program progress and inform program activities and to enhance case investigations for data-to-care opportunities, and strengthening health department infrastructure to expand surveillance capacity. Prevention activities include supporting viral hepatitis elimination planning, partnerships, and coordination in high-impact and healthcare settings, increasing hepatitis B and hepatitis C testing, treatment, and service integration in high-impact settings, and developing perinatal hepatitis C programs. Expected outcomes include improved surveillance and reporting of viral hepatitis, improved strategic planning and partner collaboration in viral hepatitis elimination, and expanded access to viral hepatitis prevention, diagnosis, and treatment in high-impact settings.
This multi-component NOFO includes two required components and two optional components:
- Component 1: Outbreak Response and Surveillance (Required)
- Component 2: Planning, Partnerships, and Promotion (Required)
- Component 3: Testing, Treatment, and Prevention (Optional)
- Component 4: Perinatal Hepatitis C Program (Optional)
This NOFO is alignment with CDC priorities.
Who Can Apply
Eligible Applicant Types
Funding Details
- Total Program Funding
- $450.0M
- Expected Number of Awards
- 60
- Cost Sharing Required?
- No
- Funding Instrument
- cooperative_agreement
Key Dates
Agency Contact
Clarisse Tsang 404-718-5360
mix4@cdc.govReady to apply?
View the full NOFO and submit your application on Grants.gov